Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicalutamide plus oral minoxidil for female pattern hair loss
RBR-2q4ht7rPhase 3Completed
- Sponsor
- UNESP Botucatu Medical School
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Female Pattern Hair Loss (FPHL) and alopecia areata comparing Bicalutamide plus minoxidil with Minoxidil plus placebo (2 arms). Started Sep 2022; status: completed.
02
Drugs
bicalutamideminoxidil
03
Conditions
Female Pattern Hair Loss (FPHL)alopecia areata
Beyond the preview
Go deeper on RBR-2q4ht7r.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2q4ht7r.